VIVXF (Avivagen) Stock Based Compensation: $0.07 Mil (TTM As of Jul. 2023)


What is Avivagen Stock Based Compensation?

Avivagen VIVXF -99.00% Stock Based Compensation is $0.07 Mil as of Jul. 2023.

Avivagen's Stock Based Compensation for the three months ended in Jul. 2023 was $0.01 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jul. 2023 was $0.07 Mil.

Avivagen Stock Based Compensation Related Terms

Avivagen Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Avivagen's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avivagen Stock Based Compensation Chart

Avivagen Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.44 0.24 0.24 0.26 0.11

Avivagen Quarterly Data
Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.03 0.02 0.01 0.01

Avivagen Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jul. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.07 Mil.

What does a Stock Based Compensation of $0.07 Mil mean?
Avivagen (VIVXF) has a Stock Based Compensation of $0.07 Mil as of Jul. 2023. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Avivagen and its competitors.
Is Avivagen's Stock Based Compensation too high?
Avivagen's current Stock Based Compensation is $0.07 Mil.
How does Avivagen's Stock Based Compensation compare to DMKPQ and MJNE?
Avivagen's Stock Based Compensation of $0.07 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Drug Manufacturers company?
A good Stock Based Compensation depends on the Drug Manufacturers industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Avivagen and its competitors. Avivagen's current Stock Based Compensation is $0.07 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avivagen stock overvalued right now?
Avivagen (VIVXF) has a current Stock Based Compensation of $0.07 Mil. The current Stock Based Compensation is $0.07 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Avivagen (VIVXF), the current Stock Based Compensation is $0.07 Mil as of Jul. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avivagen Business Description

Address 100 Sussex Drive, Ottawa, ON, CAN, K1A 0R6
Avivagen Inc OxC-beta technology is derived from Avivagen discoveries about Beta-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colours. Through support of immune function the technology provides a non-antibiotic means of promoting health and growth. OxCbeta Livestock is a proprietary product shown to be an effective and economic alternative to the antibiotics commonly added to livestock feeds. Avivagen's OxC-beta Livestock product is safe, effective and could fulfill the global mandate to remove all in-feed antibiotics as growth promoters.